Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 44 of 44 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 01/10/24
End: 12/31/25
Due: 12/31/26
Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 02/10/20
Due: 02/10/21
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 08/31/18
Due: 08/31/19
Phase: N/A
Priority: Normal
Start: 11/10/23
End: 01/01/27
Due: 01/01/28
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 05/01/18
Due: 05/01/19
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 01/04/20
End: 10/01/20
Due: 10/01/21
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 12/01/18
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 04/30/20
Due: 04/30/21
Phase: N/A
Priority: Normal
Start: 04/01/17
End: 02/01/18
Due: 02/01/19
Phase: N/A
Priority: Normal
Start: 10/10/21
End: 12/03/21
Due: 12/03/22